natgillin/translations-raw huggingface dataset:
Anprisningen bør, med en ændret formulering, under hensyntagen til især kravet i artikel 5, stk. 2, i forordning (EF) nr. 1924/2006 anses for at opfylde kravene i forordning (EF) nr. 1924/2006 og bør optages på EU-listen over tilladte anprisninger.
Subject to a revised wording, taking into account in particular the requirement referred to Article 5(2) of Regulation (EC) No 1924/2006, the claim should be considered as complying with the requirements of Regulation (EC) No 1924/2006, and it should be included in the Community list of permitted claims.
Et af målene med forordning (EF) nr. 1924/2006 er at sikre, at sundhedsanprisninger er sandfærdige, klare, pålidelige og anvendelige for forbrugeren, og i den forbindelse at formuleringen og præsentationen af sundhedsanprisninger tages i betragtning.
One of the objectives of the Regulation (EC) No 1924/2006 is to ensure that health claims are truthful, clear and reliable and useful to the consumer, and that wording and presentation are taken into account in that respect.
Anprisninger, der anvendes af ansøgeren, og som i kraft af deres formulering har samme betydning for forbrugerne som en godkendt sundhedsanprisning, idet de viser den samme sammenhæng mellem en fødevarekategori, en fødevare eller en af dens bestanddele og sundhed, bør derfor også være omfattet af de samme anvendelsesbetingelser, jf. bilaget til denne afgørelse.
Therefore, where the wording of claims used by the applicant has the same meaning for consumers as that of an authorised health claim, because they demonstrate the same relationship that exists between a food category, a food or one of its constituents and health, they should be subject to the same conditions of use, as indicated in the Annex to the present Decision.
Autoriteten bemærkede i sin udtalelse, at den ikke ville have kunnet drage sin konklusion uden at have taget de ni undersøgelser, som ansøgeren havde angivet som værende omfattet af ejendomsrettigheder, i betragtning.
The Authority indicated in its opinion that its conclusions could not have been reached without considering the nine studies claimed by the applicant as proprietary.
Efter at have modtaget autoritetens udtalelse henvendte Kommissionen sig til ansøgeren igen for at få uddybet den begrundelse, der var givet vedrørende de ni undersøgelser, som var angivet som værende omfattet af ejendomsrettigheder, navnlig vedrørende den »eneret på at kunne henvise«, der henvises til i artikel 21, stk. 1, litra b), i forordning (EF) nr. 1924/2006.
Following the receipt of the Authority’s opinion, the Commission went back to the applicant for further clarification on the justification provided regarding the nine studies claimed as proprietary and in particular regarding the ‘exclusive right of reference’ as referred to in Article 21(1)(b) of Regulation (EC) No 1924/2006.
Alle oplysninger, der er fremlagt af ansøgeren til begrundelse af anmodningen, er blevet gennemgået.
All the justifiable information provided by the applicant has been assessed.
Hvad angår de syv ikke offentliggjorte undersøgelser anses kravene i artikel 21, stk. 1, i forordning (EF) nr. 1924/2006 for at være opfyldt.
For the seven unpublished studies it is considered that the requirements laid down in Article 21(1) of Regulation (EC) No 1924/2006 are fulfilled.
De videnskabelige data og andre oplysninger i disse syv undersøgelser må derfor i fem år efter godkendelsesdatoen ikke anvendes til fordel for en efterfølgende ansøger, jf. betingelserne i forordningens artikel 21, stk. 1.
Accordingly, the scientific data and other information included in the seven studies may not be used for the benefit of a subsequent applicant for a period of 5 years from the date of authorisation, under the conditions laid down in Article 21(1) of that Regulation.
For de to undersøgelser, som var blevet offentliggjort forud for indgivelsen af ansøgningen om godkendelse af sundhedsanprisningen [3], vurderes det, at eftersom undersøgelserne er blevet offentliggjort og gjort tilgængelige i det offentlige domæne, er der ikke grundlag for at anmode om beskyttelse af dem i henhold til målene med forordning (EF) nr. 1924/2006, som blandt andet er at beskytte den investering, som produktudviklere foretager ved indsamling af oplysninger og data til støtte for en ansøgning, der indgives i henhold til samme forordning, og anmodningen bør derfor ikke imødekommes.
For the two studies, which had been published prior to the submission of the application for authorisation of the health claim [3], it is considered that as the studies have been published and made available to the public domain, their protection is not justified in the light of the objectives of Regulation (EC) No 1924/2006 among which to protect the investment made by innovators in gathering the information and data supporting an application under that Regulation and accordingly it should not be granted.
De bemærkninger fra ansøgeren, som Kommissionen har modtaget i overensstemmelse med artikel 16, stk. 6, i forordning (EF) nr. 1924/2006, er taget i betragtning ved fastsættelsen af foranstaltningerne i denne afgørelse.
The comments from the applicant received by the Commission, pursuant to Article 16(6) of Regulation (EC) No 1924/2006, have been considered when setting the measures provided for in this Decision.
Medlemsstaterne er blevet hørt —
The Member States have been consulted,
Den i bilaget til nærværende afgørelse angivne sundhedsanprisning optages på den i artikel 13, stk. 3, i forordning (EF) nr. 1924/2006 omhandlede EU-liste over tilladte anprisninger.
The health claim set out in the Annex to this Decision shall be included in the Community list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
De videnskabelige data og andre oplysninger i de i bilaget til denne afgørelse angivne undersøgelser må i fem år efter godkendelsesdatoen kun anvendes til fordel for ansøgeren, jf. betingelserne i artikel 21, stk. 1, i forordning (EF) nr. 1924/2006.
The scientific data and other information included in the studies identified in the Annex to this Decision shall be restricted for use for the benefit of the applicant for a period of 5 years from the date of authorisation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.
Denne afgørelse er rettet til Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Det Forenede Kongerige
This Decision is addressed to Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom
EFSA Journal (2009) 1101, s. 1.
The EFSA Journal (2009) 1101, pp. 1-15.
Ansøger — adresse
Applicant — Address
Næringsstof, andet stof, fødevare eller fødevarekategori
Nutrient, substance, food or food category
Anprisning
Claim
Betingelser for anvendelsen af anprisningen
Conditions of use of the claim
Betingelser og/eller begrænsninger for anvendelsen af fødevaren og/eller supplerende erklæringer eller advarsler
Conditions and/or restrictions of use of the food and/or additional statement or warning
Data, som er omfattet af ejendomsrettigheder og kun må anvendes til fordel for ansøgeren
Proprietary data restricted for use for the benefit of the applicant
EFSA-udtalelse
EFSA opinion reference
Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Det Forenede Kongerige
Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom
Vandopløseligt tomatkoncentrat (WSTC) I og II
Water-Soluble Tomato Concentrate (WSTC) I and II
Vandopløseligt tomatkoncentrat (WSTC) I og II hjælper til at opretholde en normal trombocytaggregation, hvilket bidrager til en sund blodgennemstrømning
Water-Soluble Tomato Concentrate (WSTC) I and II helps maintain normal platelet aggregation, which contributes to healthy blood flow
Forbrugerne informeres om, at den gavnlige effekt opnås ved en daglig indtagelse af 3 g WSTC I eller 150 mg WSTC II i op til 250 ml frugtsaft, aromatiserede drikkevarer eller yoghurtdrikke (dog ikke højpasteuriserede produkter)
Information to the consumer that the beneficial effect is obtained with a daily consumption of 3g WSTC I or 150 mg WSTC II in up to 250 ml of either fruit juices, flavoured drinks or yogurt drinks (unless heavily pasteurised)
O’Kennedy, N., Crosbie, L., van Lieshout, M., Broom, J.I., Webb, D.J., og Duttaroy, A.K., 2003a.
O’Kennedy, N., Crosbie, L., van Lieshout M., Broom J.I., Webb, D.J., Duttaroy, A.K., 2003a.
Song, V., Sheddon, A., Horgan, G., og O’Kennedy, N.: Anticoagulatory and antiinflammatory activities of WSTC in platelets and endothelial cells.
Song, V., Sheddon, A., Horgan, G. and O’Kennedy, N. Anticoagulatory and anti-inflammatory activities of WSTC in platelets and endothelial cells.
Manuskript til fremlæggelse; 2008
Manuscript for submission; 2008.
Zhang, F., Song, V., Neascu, M., Crosbie, L., Duncan, G., Horgan, G., de Roos, B., og O’Kennedy, N.: Flow cytometric and proteomic studies examining the effects of WSTC on platelet function in vitro.
Zhang, F., Song, V., Neascu, M., Crosbie, L., Duncan, G., Horgan, G., de Roos, B. and O’Kennedy, N. Flow cytometric and proteomic studies examining the effects of WSTC on platelet function in vitro.
Ikke offentliggjort, 2007/08.
Unpublished, 2007/2008.
O’Kennedy, N., Crosbie, L., Whelam, S., Luther, V., Horgan, G., Broom, J.I., Webb, D.J., og Duttaroy, A.K.: Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans, American Journal of Clinical Nutrition, 2006 vol. 84, s. 561, og O’Kennedy, N., Crosbie, L., van Lieshout, M., Broom, J.I., Webb, D.J., og Duttaroy, A.K.: Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans.
O’Kennedy, N., Crosbie, L., Whelam, S., Luther, V., Horgan, G., Broom, J.I., Webb, D.J., Duttaroy, A.K., Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans, The American Journal of Clinical Nutrition, 2006, Vol. 84, pp. 561-569 and O’Kennedy N., Crosbie, L., van Lieshout, M., Broom, J.I., Webb, D.J., Duttaroy, A.K., Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans.
American Journal of Clinical Nutrition, 2006, vol. 84, s. 570.
The American Journal of Clinical Nutrition, 2006, Vol. 84, pp. 570-579.
Dok. nr. 02/0269
REC No 02/0269
O’Kennedy et al., 2003b: A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers.
O’Kennedy et al. 2003b. A 42-day randomised, controlled and double-blinded crossover study to evaluate effects of daily WSTC consumption on platelet function, coagulation and some baseline CVD risk markers.
Dok. nr. 03/0177.
REC No 03/0177.
O’Kennedy et al., 2005: Effects of overconsuming Sirco®, a one-a-day fruit juice drink containing 12g/L WSTC, on platelet function in healthy subjects.
O’Kennedy et al. 2005. Effects of overconsuming Sirco®, a one-a-day fruit juice drink containing 12g/L WSTC, on platelet function in healthy subjects.
Dok. nr. 05/S0802/77.
REC No 05/S0802/77.
O’Kennedy et al., 2006c: A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices.
O’Kennedy et al. 2006c. A pilot study to compare the antiplatelet effects of WSTC in healthy subjects, after consumption in two different food matrices.
Dok. nr. 06/S0802/60.
REC No 06/S0802/60.
O’Kennedy et al., 2007: A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans.
O’Kennedy et al. 2007. A randomised, controlled and double-blinded crossover study to compare the antiplatelet effects of three different formats of WSTC in healthy humans.
Dok. nr. 07/S0801/13.
REC No 07/S0801/13.
Rådets afgørelse 2009/981/FUSP
Council Decision 2009/981/CFSP
af 18. december 2009
of 18 December 2009
Der er ikke længere grund til fortsat at lade en bestemt person være opført på listen over personer, enheder og organer, som fælles holdning 2006/318/FUSP finder anvendelse på —
There are no longer grounds for keeping one person on the list of persons, entities and bodies to which Common Position 2006/318/CFSP applies,
Den person, der er nævnt i bilaget til denne afgørelse, fjernes fra listen i bilag II til fælles holdning 2006/318/FUSP.
The person mentioned in the Annex to this Decision shall be removed from the list set out in Annex II to Common Position 2006/318/CFSP.
Udfærdiget i Bruxelles, den 18. december 2009.
Done at Brussels, 18 December 2009.
DEN I ARTIKEL 1 OMHANDLEDE PERSON
PERSON REFERRED TO IN ARTICLE 1
Identifikationsoplysninger
Identifying information
(herunder ministerium)
(inc. Ministry)
(menes for øjeblikket at opholde sig i UK, rejste ind før optagelsen på listen)
(believed to be currently in UK; went before entered on list)
Afgørelse EUJUST LEX/2/2009 vedtaget af Den Udenrigs- og Sikkerhedspolitiske Komité
Political and Security Committee Decision EUJUST LEX/2/2009
om udnævnelse af missionschefen for Den Europæiske Unions integrerede retsstatsmission for Irak, EUJUST LEX
concerning the appointment of the Head of Mission for the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX
(2009/982/FUSP)
(2009/982/CFSP)
under henvisning til Rådets fælles aktion 2009/475/FUSP af 11. juni 2009 om Den Europæiske Unions integrerede retsstatsmission for Irak, EUJUST LEX, særlig artikel 9, stk. 2, og
Having regard to Council Joint Action 2009/475/CFSP of 11 June 2009 on the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX, and in particular Article 9(2) thereof,
Unionens højtstående repræsentant for udenrigsanliggender og sikkerhedspolitik har foreslået, at Francisco DÍAZ ALCANTUD udnævnes til missionschef for EUJUST LEX indtil den 30. juni 2010 —
The High Representative of the Union for Foreign Affairs and Security Policy has proposed that Mr Francisco DÍAZ ALCANTUD be appointed as Head of Mission of EUJUST LEX until 30 June 2010.
Francisco DÍAZ ALCANTUD udnævnes til missionschef for Den Europæiske Unions integrerede retsstatsmission for Irak, EUJUST LEX, for perioden fra den 1. januar 2010 til den 30. juni 2010.
Mr Francisco DÍAZ ALCANTUD is hereby appointed as Head of Mission of the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX, for the period from 1 January 2010 until 30 June 2010.
Denne afgørelse meddeles Francisco DÍAZ ALCANTUD.
This Decision shall be notified to Mr Francisco DÍAZ ALCANTUD.
om Republikken Litauens myndigheders ydelse af statsstøtte til køb af statsejet landbrugsjord mellem den 1. januar 2010 og den 31. december 2013
on the granting of State aid by the authorities of the Republic of Lithuania for the purchase of State-owned agricultural land between 1 January 2010 and 31 December 2013
under henvisning til traktaten om Den Europæiske Unions funktionsmåde, særlig artikel 108, stk. 2, tredje afsnit,
Having regard to the Treaty on the Functioning of the European Union and in particular Article 108(2), third subparagraph, thereof,
under henvisning til begæring indgivet af Republikken Litauens regering den 23. november 2009, og
Having regard to the request made by the Government of the Republic of Lithuania on 23 November 2009,
Den 23. november 2009 fremsatte Republikken Litauen (i det følgende benævnt »Litauen«) en begæring til Rådet om i overensstemmelse med artikel 88, stk. 2, tredje afsnit, i traktaten om oprettelse af Det Europæiske Fællesskab at træffe beslutning om Litauens plan om at yde statsstøtte til litauiske landmænd til køb af statsejet landbrugsjord.
On 23 November 2009, the Republic of Lithuania (hereinafter referred to as ‘Lithuania’) presented to the Council a request for a decision in accordance with the third subparagraph of Article 88(2) of the Treaty establishing the European Community concerning Lithuania’s plan to grant State aid to Lithuanian farmers for the purchase of State-owned agricultural land.
På grund af utilstrækkelige landbrugsindkomster er det vanskeligt at forbedre de litauiske landbrugsbedrifters ugunstige arealstruktur.
Due to insufficient agricultural incomes, it is difficult to improve the unfavourable area structure of Lithuanian agricultural holdings.
I 2009 udgjorde bedrifter med et areal på op til 5 hektar 52,5 % af alle bedrifter.
In 2009, farms with an area of up to 5 hectares made up 52,5 % of all farms.
I 2009 medførte den økonomiske og finansielle krise et væsentligt fald i producentpriserne på landbrugsprodukter i Litauen: I første kvartal faldt producentpriserne med 27 % sammenlignet med første kvartal af 2008, i andet kvartal med 25,3 % sammenlignet med andet kvartal af 2008 og i tredje kvartal med 8 % sammenlignet med tredje kvartal af 2008.
In 2009, the economic and financial crisis substantially decreased producer prices of agricultural products in Lithuania: in the first quarter, the producer prices of agricultural products declined by 27 % compared to the first quarter of 2008, by 25,3 % in the second quarter compared to the second quarter of 2008 and by 8 % in the third quarter compared to the third quarter of 2008.
Producentpriserne på afgrøder er blevet specielt hårdt ramt af dette fald: I samme referenceperiode faldt de med henholdsvis 33,6 %, 35,7 % og 17,9 %.
Crop producer prices have been especially significantly hit by this decrease: over the same reference period producer prices of crop products declined accordingly by 33,6 %, 35,7 % and 17,9 %.
I betragtning af landmændenes mangel på egenkapital og kreditinstitutternes høje rentesatser på lån til køb af landbrugsjord blev landmændenes udsigter til at optage lån til investeringer som f.eks. køb af landbrugsjord på markedsvilkår drastisk forringet i slutningen af 2008 og i 2009.
At the end of 2008 and in 2009, in view of the lack of equity capital of farmers and the high interest rates applied by credit institutions on loans for the purchase of agricultural land, the prospects for farmers of taking out loans for investments such as the purchase of agricultural land at market conditions were drastically reduced.
I fjerde kvartal af 2008 og i 2009 har renterne på kreditter til køb af landbrugsjord ligget på mellem 9,51 % og 15,99 % p.a.
In the fourth quarter of 2008 and in 2009, credit interest rates on loans for the purchase of agricultural land varied between 9,51 % to 15,99 % per annum.
Der vil blive ydet to alternative former for statsstøtte: 1) ved at multiplicere markedsprisen på købt jord med en vejningsfaktor (0,6 eller 0,75 for unge landmænd, hvis alle støtteordningens betingelser er opfyldt) og 2) ved at sælge statsejet landbrugsjord på en ratebasis, idet støtten i så fald svarer til forskellen mellem den faktiske rente, som køber har betalt, på minimum 5 %, og den långivende banks rentesats.
The State aid will be provided in two alternative forms: 1) by multiplying the market price of the purchased land by a weighting factor (0,6 or 0,75 for young farmers if all the conditions set in the aid scheme are fulfilled); 2) by selling the State-owned agricultural land on an instalment basis, in which case the aid corresponds to the difference between the actual interest rate paid by the purchaser, which is minimum 5 %, and the interest rate applied by the lending bank.
Den planlagte statsstøtte beløber sig til maksimalt 55 mio. litauiske litas (LTL) og skulle muliggøre køb af i alt 370000 hektar landbrugsjord i perioden 2010-2013, i form af maksimalt 300 hektar landbrugsjord pr. køber.
The State aid to be granted amounts to a maximum of LTL 55 million and should enable the purchase of a total of 370000 hectares of agricultural land — in the form of a maximum of 300 hectares of agricultural land per purchaser — during the period from 2010 to 2013.
Det gennemsnitlige støttebeløb pr. bedrift forventes at ligge på ca. 11000 LTL.
The average amount of aid per holding should be approximately LTL 11000.
Jorden kan sælges til fysiske personer, der opfylder følgende betingelser: De har indgivet en enkeltansøgning under de arealrelaterede støtteordninger i overensstemmelse med artikel 11 i Kommissionens forordning (EF) nr. 796/2004 af 21. april 2004 om gennemførelsesbestemmelser vedrørende krydsoverensstemmelse, graduering og det integrerede forvaltnings- og kontrolsystem som omhandlet i Rådets forordning (EF) nr. 1782/2003 om fastlæggelse af fælles regler for den fælles landbrugspolitiks ordninger for direkte støtte og om fastlæggelse af visse støtteordninger for landbrugere [1] i det år, der ligger forud for året for indgivelsen af deres ansøgning om statsstøtte; de forvalter bedriftens regnskab; de har praktisk landbrugserfaring og har en registreret bedrift, eller de har praktisk landbrugserfaring og et landbrugsdiplom eller et dokument, der attesterer en landbrugsuddannelse.
The land may be sold to natural persons who fulfil the following conditions: they have submitted a ‘single application’ in respect of the area-related aid schemes in accordance with Article 11 of Commission Regulation (EC) No 796/2004 of 21 April 2004 laying down detailed rules for the implementation of cross-compliance, modulation and the integrated administration and control system provided for in Council Regulation (EC) No 1782/2003 establishing common rules for direct support schemes under the common agricultural policy and establishing certain support schemes for farmers [1] in the year preceding the year of submission of their application for State aid; they manage the farm accountancy; they have experience in practical farming and have a registered farm or they have experience in practical farming and hold a diploma in the area of agriculture or a document certifying vocational training in farming.
Jorden kan også sælges til juridiske personer, når mindst halvdelen af deres årlige indkomst stammer fra salg af afsættelige landbrugsprodukter, og der foreligger bevis for deres økonomiske levedygtighed.
The land may also be sold to legal persons, for which at least half of the annual income is made up of proceeds of sales of marketable agricultural products and for which there is proof of their economic viability.
Statsejet landbrugsjord kan sælges i rater over en periode på højst 15 år, idet køberen begynder at betale fra det andet år og betaler 10 % af prisen med det samme, bortset fra unge landmænd under 40 år, der kun skal betale 5 %.
State-owned agricultural land can be sold in instalments over a period of no longer than 15 years, the purchaser starting to pay as from the second year and paying 10 % of the price outright, except for young farmers under 40 years of age, who need only pay 5 %.
Køberen skal opfylde minimumsstandarder for miljøbeskyttelse, hygiejne og dyrevelfærd.
The purchaser must meet the minimum standards of environment protection, hygiene and animal welfare.
Der anvendes ingen udbudsprocedure for statsejet landbrugsjord, men prisen beregnes i overensstemmelse med den litauiske lov om reglerne for ejendoms- og erhvervsvurdering, dvs. efter værdiansættelse af hvert enkelt stykke land til markedspris.
No tendering procedure applies for State-owned agricultural land but the price is calculated according to the Lithuanian Law on Foundations of Property and Business Valuation, i.e. after evaluation of the properties of each land plot at market price.
Prisen beregnet i overensstemmelse hermed vægtes med 0,6 %, når unge landmænd under 40 år, der har anvendt den pågældende jord i mindst et år, betaler for den med det samme.
A weighting of 0,6 applies to the price so calculated if young farmers under 40 years of age who have used the land in question for at least 1 year, pay for it outright.
Prisen vægtes med 0,75 %, når unge landmænd under 40 år, der har anvendt den pågældende jord i mindst et år, betaler for den i rater.
A weighting of 0,75 applies in the case of young farmers under 40 years of age who have used the land in question for at least 1 year, pay for the land in instalments.